Annexon

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.

About ANNX

Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy. 

CEO
Douglas Love
CEODouglas Love
Employees
61
Employees61
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2011
Founded2011
Employees
61
Employees61

ANNX Key Statistics

Market cap
294.28M
Market cap294.28M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
150.22K
Average volume150.22K
High today
$6.29
High today$6.29
Low today
$5.89
Low today$5.89
Open price
$5.89
Open price$5.89
Volume
91.55K
Volume91.55K
52 Week high
$22.34
52 Week high$22.34
52 Week low
$2.06
52 Week low$2.06

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

ANNX Earnings

-$0.97
-$0.65
-$0.32
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.